AMAG Pharmaceuticals Company Profile (NASDAQ:AMAG)

About AMAG Pharmaceuticals

AMAG Pharmaceuticals logoAMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units operated through Cord Blood Registry (CBR); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AMAG
  • CUSIP: 00163U10
Key Metrics:
  • Previous Close: $23.35
  • 50 Day Moving Average: $32.19
  • 200 Day Moving Average: $27.45
  • 52-Week Range: $17.92 - $36.83
  • Trailing P/E Ratio: 56.78
  • Foreward P/E Ratio: 10.38
  • P/E Growth: -2.27
  • Market Cap: $844.96M
  • Outstanding Shares: 34,209,000
  • Beta: 1.01
Profitability:
  • Net Margins: 3.12%
  • Return on Equity: 11.10%
  • Return on Assets: 4.13%
Debt:
  • Debt-to-Equity Ratio: 0.99%
  • Current Ratio: 2.24%
  • Quick Ratio: 2.12%
Additional Links:
Companies Related to AMAG Pharmaceuticals:

Analyst Ratings

Consensus Ratings for AMAG Pharmaceuticals (NASDAQ:AMAG) (?)
Ratings Breakdown: 1 Sell Rating, 8 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.23)
Consensus Price Target: $35.91 (45.38% upside)

Analysts' Ratings History for AMAG Pharmaceuticals (NASDAQ:AMAG)
Show:
DateFirmActionRatingPrice TargetDetails
1/12/2017Cantor FitzgeraldReiterated RatingNeutral$33.00View Rating Details
1/11/2017Needham & Company LLCDowngradeBuy -> HoldView Rating Details
1/10/2017Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details
1/10/2017Leerink SwannDowngradeOutperform -> Market Perform$39.00 -> $25.00View Rating Details
1/9/2017Raymond James Financial Inc.Reiterated RatingMarket Perform -> UnderperformView Rating Details
11/7/2016GuggenheimInitiated CoverageBuy$42.00View Rating Details
11/4/2016JPMorgan Chase & Co.Reiterated RatingHold$33.00View Rating Details
8/10/2016Jefferies GroupLower Price TargetBuy$58.00 -> $45.00View Rating Details
5/9/2016Deutsche Bank AGLower Price TargetHold$42.00 -> $35.00View Rating Details
3/28/2016Robert W. BairdLower Price TargetOutperform$26.00 -> $25.00View Rating Details
3/28/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details
1/28/2016Northland SecuritiesInitiated CoverageOutperform$40.00View Rating Details
1/21/2016Barclays PLCInitiated CoverageEqual Weight$32.00View Rating Details
3/9/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details
1/26/2015FBR & CoReiterated RatingMarket Perform$42.00View Rating Details
(Data available from 1/19/2015 forward)

Earnings

Earnings History for AMAG Pharmaceuticals (NASDAQ:AMAG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017        
11/3/2016Q316$1.50$1.78$141.65 million$143.80 millionViewListenView Earnings Details
8/9/2016Q216$1.20$1.45$128.52 million$127.40 millionViewListenView Earnings Details
5/3/2016Q116$1.11$0.94$124.83 million$117.60 millionViewListenView Earnings Details
2/17/2016Q415$1.16$1.12$120.13 million$108.70 millionViewListenView Earnings Details
11/3/2015Q315$1.21$1.02$113.88 million$103.50 millionViewListenView Earnings Details
7/23/2015Q215$0.75$1.12$94.05 million$123.90 millionViewListenView Earnings Details
5/5/2015Q115$1.04$1.11$84.66 million$89.50 millionViewListenView Earnings Details
2/9/2015Q414$0.30$0.06$52.69 million$53.30 millionViewListenView Earnings Details
10/30/2014Q314($0.08)$0.06$26.30 million$25.50 millionViewListenView Earnings Details
7/29/2014Q214($0.09)($0.07)$23.40 million$24.80 millionViewListenView Earnings Details
4/24/2014Q1($0.07)($0.33)$22.73 million$20.80 millionViewListenView Earnings Details
2/6/2014Q4($0.10)($0.17)$21.01 million$21.70 millionViewListenView Earnings Details
10/17/2013Q313($0.12)($0.01)$20.37 million$21.60 millionViewListenView Earnings Details
8/1/2013Q2 2013($0.17)($0.09)$18.51 million$19.60 millionViewListenView Earnings Details
4/23/2013Q1 2013($0.20)($0.18)$17.99 million$17.90 millionViewListenView Earnings Details
3/1/2013Q4 2012($0.06)($0.17)$22.54 million$21.14 millionViewN/AView Earnings Details
11/1/2012Q312($0.26)($0.19)$20.43 million$17.70 millionViewN/AView Earnings Details
7/26/2012($0.39)$0.16ViewN/AView Earnings Details
5/1/2012($0.63)($0.58)ViewN/AView Earnings Details
3/5/2012($1.09)($0.87)ViewN/AView Earnings Details
11/4/2011($0.98)($0.78)ViewN/AView Earnings Details
5/3/2011($0.99)($1.05)ViewN/AView Earnings Details
2/25/2011($1.04)($0.94)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AMAG Pharmaceuticals (NASDAQ:AMAG)
Current Year EPS Consensus Estimate: $0.47 EPS
Next Year EPS Consensus Estimate: $2.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.13$0.68$0.36
Q2 20163$0.14$0.76$0.54
Q3 20163$0.38$0.90$0.71
Q4 20162$0.32$0.44$0.38
Q1 20171($1.05)($1.05)($1.05)
Q2 20171$0.58$0.58$0.58
Q3 20171$0.43$0.43$0.43
Q4 20171$0.57$0.57$0.57
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AMAG Pharmaceuticals (NASDAQ:AMAG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AMAG Pharmaceuticals (NASDAQ:AMAG)
Insider Ownership Percentage: 2.30%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/20/2016Julie KropSVPSell4,938$24.80$122,462.40View SEC Filing  
11/10/2015John A FallonDirectorBuy3,230$31.20$100,776.00View SEC Filing  
10/1/2015William K HeidenCEOSell2,000$39.69$79,380.00View SEC Filing  
9/1/2015William K HeidenCEOSell2,000$61.19$122,380.00View SEC Filing  
7/15/2015William K HeidenCEOSell20,000$75.00$1,500,000.00View SEC Filing  
6/15/2015Scott A HolmesSVPSell7,580$66.63$505,055.40View SEC Filing  
6/5/2015William K HeidenCEOSell66,875$69.90$4,674,562.50View SEC Filing  
6/4/2015Frank E ThomasCOOSell20,000$69.47$1,389,400.00View SEC Filing  
6/3/2015Scott A HolmesSVPSell22,516$68.88$1,550,902.08View SEC Filing  
1/9/2015Adage Capital Partners Gp LlcMajor ShareholderSell1,250,000$46.49$58,112,500.00View SEC Filing  
1/9/2014Christopher WhiteInsiderSell4,000$22.37$89,480.00View SEC Filing  
1/7/2014Christopher WhiteInsiderSell5,000$23.90$119,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AMAG Pharmaceuticals (NASDAQ:AMAG)
DateHeadline
News IconTarget Price Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) At $34.111 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - January 15 at 3:28 PM
News IconTarget Price Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) At $34.111 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - January 15 at 3:28 PM
capitalcube.com logoAMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : January 10, 2017 (NASDAQ:AMAG)
us.rd.yahoo.com - January 11 at 8:49 PM
marketexclusive.com logoAnalyst Downgrades – AMAG Pharmaceuticals (NASDAQ:AMAG) Stock Gets Downgraded By Needham & Company ... - Market Exclusive (NASDAQ:AMAG)
marketexclusive.com - January 11 at 3:47 PM
finance.yahoo.com logoAMAG Pharma downgraded by Needham (NASDAQ:AMAG)
finance.yahoo.com - January 11 at 3:47 PM
capitalcube.com logoAMAG Pharmaceuticals, Inc. – Value Analysis (NASDAQ:AMAG) : January 11, 2017 (NASDAQ:AMAG)
www.capitalcube.com - January 11 at 3:47 PM
finance.yahoo.com logoPalatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda™ (NASDAQ:AMAG)
finance.yahoo.com - January 10 at 8:31 PM
globenewswire.com logoAMAG Pharmaceuticals Provides Financial and Business Update - GlobeNewswire (press release) (NASDAQ:AMAG)
globenewswire.com - January 10 at 3:31 PM
fool.com logoWhy AMAG Pharmaceuticals, Inc. Is Falling Today - Motley Fool (NASDAQ:AMAG)
www.fool.com - January 10 at 3:31 PM
streetinsider.com logoAMAG Pharma (AMAG) Offers Q4 and FY17 Guidance (NASDAQ:AMAG)
www.streetinsider.com - January 9 at 8:42 PM
marketexclusive.com logoAMAG Pharmaceuticals,Inc. (NASDAQ:AMAG) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:AMAG)
marketexclusive.com - January 9 at 8:42 PM
us.rd.yahoo.com logoAMAG Pharmaceuticals Provides Financial and Business Update (NASDAQ:AMAG)
us.rd.yahoo.com - January 9 at 8:42 PM
us.rd.yahoo.com logo8:04 am AMAG Pharma sees Q4 rev below consensus; FY17 rev in-line; (NASDAQ:AMAG)
us.rd.yahoo.com - January 9 at 8:42 PM
biz.yahoo.com logoAMAG PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and F (NASDAQ:AMAG)
us.rd.yahoo.com - January 9 at 8:42 PM
us.rd.yahoo.com logoAMAG Pharma downgraded by Raymond James (NASDAQ:AMAG)
us.rd.yahoo.com - January 9 at 8:42 PM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) EPS Estimated At $0.7 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - January 9 at 3:40 PM
seekingalpha.com logoAMAG Pharma -35%; Raymond James downgrades - Seeking Alpha (NASDAQ:AMAG)
seekingalpha.com - January 9 at 3:40 PM
finance.yahoo.com logoAMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights ... - Yahoo Finance (NASDAQ:AMAG)
finance.yahoo.com - January 9 at 3:40 PM
News IconWhy AMAG Pharmaceuticals, Inc. Is Falling Today - Fox Business (NASDAQ:AMAG)
www.foxbusiness.com - January 9 at 3:40 PM
fool.com logoWhy AMAG Pharmaceuticals, Inc. Is Falling Today (NASDAQ:AMAG)
www.fool.com - January 9 at 1:55 PM
feeds.benzinga.com logoAMAG Pharmaceuticals Tanks After Raymond James Downgrade (NASDAQ:AMAG)
feeds.benzinga.com - January 9 at 12:50 PM
feeds.reuters.com logoBRIEF-Amag Pharmaceuticals sees Q4 2016 revenue $150 mln to $155 mln (NASDAQ:AMAG)
feeds.reuters.com - January 9 at 8:52 AM
News IconCompany in Focus: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Beacon (NASDAQ:AMAG)
wsbeacon.com - January 9 at 1:38 AM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) EPS At $0.3 - Stock Observer (NASDAQ:AMAG)
www.thestockobserver.com - January 8 at 8:31 PM
News IconPrice Target Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) At $37.888 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - January 7 at 3:48 PM
News IconLong-Term Growth Estimate Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) At $-2.8 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - January 5 at 3:43 PM
marketexclusive.com logoAnalyst Activity – Janney Montgomery Scott Initiates Coverage On AMAG Pharmaceuticals (NASDAQ:AMAG) With a Buy - Market Exclusive (NASDAQ:AMAG)
marketexclusive.com - January 4 at 3:36 PM
marketexclusive.com logoAnalyst Activity – Janney Montgomery Scott Initiates Coverage On AMAG Pharmaceuticals (NASDAQ:AMAG) With a Buy (NASDAQ:AMAG)
marketexclusive.com - January 4 at 2:04 AM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Price Target Set At $37 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - January 3 at 8:55 PM
globenewswire.com logoAMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference - GlobeNewswire (press release) (NASDAQ:AMAG)
globenewswire.com - January 3 at 3:53 PM
finance.yahoo.com logoAMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:AMAG)
finance.yahoo.com - January 3 at 3:53 PM
News IconIntravenous (IV) Iron Drugs Market Demand Is Increasing In Most Part of World 2020 – PMR Report (NASDAQ:AMAG)
www.medgadget.com - January 3 at 7:31 AM
nasdaq.com logoCommit To Purchase AMAG Pharmaceuticals At $26, Earn 12.1% Annualized Using Options (NASDAQ:AMAG)
www.nasdaq.com - December 30 at 8:43 PM
News IconInvestor Wire: Keeping an Eye on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Beacon (NASDAQ:AMAG)
wsbeacon.com - December 30 at 3:42 PM
investornewswire.com logoAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Records An Impact ... - Investor Newswire (NASDAQ:AMAG)
www.investornewswire.com - December 29 at 3:33 PM
nasdaq.com logoCommit To Purchase AMAG Pharmaceuticals At $26, Earn 12.1% Annualized Using Options - Nasdaq (NASDAQ:AMAG)
www.nasdaq.com - December 29 at 3:33 PM
News IconInvestor Watch: Looking at Shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Beacon (NASDAQ:AMAG)
wsbeacon.com - December 28 at 3:27 PM
News IconEPS Estimate Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) At $0.835 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - December 27 at 3:46 PM
News IconCompany Watch for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Beacon (NASDAQ:AMAG)
wsbeacon.com - December 27 at 7:01 AM
News IconStock Watch on Shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Beacon (NASDAQ:AMAG)
wsbeacon.com - December 26 at 6:58 AM
marketexclusive.com logoAMAG PHARMACEUTICALS, INC. (NASDAQ:AMAG) Files An 8-K Departure of Directors or Certain Officers; Election of ... - Market Exclusive (NASDAQ:AMAG)
marketexclusive.com - December 25 at 6:39 AM
fool.com logoWhere Will AMAG Pharmaceuticals Be 1 Year From Now? - Motley Fool (NASDAQ:AMAG)
www.fool.com - December 25 at 6:39 AM
4-traders.com logoAMAG PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) (NASDAQ:AMAG)
www.4-traders.com - December 24 at 1:36 AM
News IconStock Spotlight: Checking on Shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Beacon (NASDAQ:AMAG)
wsbeacon.com - December 23 at 8:35 PM
News IconNews Impact Score Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) At 96 - Stock Observer (NASDAQ:AMAG)
www.thestockobserver.com - December 23 at 3:34 PM
News IconWhere Will AMAG Pharmaceuticals Be 1 Year From Now? - Madison.com (NASDAQ:AMAG)
host.madison.com - December 23 at 3:34 PM
fool.com logoWhere Will AMAG Pharmaceuticals Be 1 Year From Now? (NASDAQ:AMAG)
www.fool.com - December 23 at 11:44 AM
biz.yahoo.com logoAMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh (NASDAQ:AMAG)
biz.yahoo.com - December 22 at 8:28 PM
News IconAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Price Target Agreed At $37 - Transcript Daily (NASDAQ:AMAG)
transcriptdaily.com - December 22 at 3:28 PM
globenewswire.com logoAMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors - GlobeNewswire (press release) (NASDAQ:AMAG)
globenewswire.com - December 22 at 3:28 PM

Social

AMAG Pharmaceuticals (NASDAQ:AMAG) Chart for Thursday, January, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for AMAG Pharmaceuticals (NASDAQ:AMAG)

Earnings History Chart

Earnings by Quarter for AMAG Pharmaceuticals (NASDAQ:AMAG)

Dividend History Chart

Dividend Payments by Quarter for AMAG Pharmaceuticals (NASDAQ:AMAG)

Last Updated on 1/19/2017 by MarketBeat.com Staff